Page last updated: 2024-09-04

sodium salicylate and Prostatic Neoplasms

sodium salicylate has been researched along with Prostatic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blandino, G; Broadfield, LA; Galic, S; Houde, VP; Kemp, BE; Muti, P; O'Brien, AJ; Steinberg, GR; Tsakiridis, T; Villani, LA	1

Other Studies

1 other study(ies) available for sodium salicylate and Prostatic Neoplasms

Article	Year
Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis. The Biochemical journal, 2015, Jul-15, Volume: 469, Issue:2 Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Synergism; Embryo, Mammalian; Enzyme Activation; Female; Fibroblasts; Humans; Hypoglycemic Agents; Lipogenesis; Lung Neoplasms; Male; Metformin; Mice; Mice, Knockout; Neoplasm Proteins; Prostatic Neoplasms; Sodium Salicylate	2015

Article

Year

Salicylate activates AMPK and synergizes with metformin to reduce the survival of prostate and lung cancer cells ex vivo through inhibition of de novo lipogenesis.

The Biochemical journal, 2015, Jul-15, Volume: 469, Issue:2

Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Cell Line, Tumor; Cell Survival; Drug Synergism; Embryo, Mammalian; Enzyme Activation; Female; Fibroblasts; Humans; Hypoglycemic Agents; Lipogenesis; Lung Neoplasms; Male; Metformin; Mice; Mice, Knockout; Neoplasm Proteins; Prostatic Neoplasms; Sodium Salicylate

2015